BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rimner A, Yao X, Huang J, Antonicelli A, Ahmad U, Korst RJ, Detterbeck F, Gomez DR. Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma-An Analysis of the International Thymic Malignancies Interest Group Retrospective Database. J Thorac Oncol. 2016;11:1785-1792. [PMID: 27346413 DOI: 10.1016/j.jtho.2016.06.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Van Raemdonck D, Ruffini E. Thymic malignancies: does size matter? Eur J Cardiothorac Surg 2016;50:1075-6. [DOI: 10.1093/ejcts/ezw267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Fan C, Ge H, Zhang S, Xing W, Ye K, Zheng Y, Sun H, Wang H, Zheng X, Zhang R, Liu M. Impact of Definitive Radiotherapy and Surgical Debulking on Treatment Outcome and Prognosis for Locally Advanced Masaoka-Koga stage III Thymoma. Sci Rep 2020;10:1735. [PMID: 32015469 DOI: 10.1038/s41598-020-58692-2] [Reference Citation Analysis]
3 Tang EK, Chang JM, Chang CC, Wu SY, Huang WL, Chen YY, Kam HH, Yen YT, Tseng YL. Prognostic Factor of Completely Resected and Pathologic T3 N0 M0 Thymic Epithelial Tumor. Ann Thorac Surg 2021;111:1164-73. [PMID: 32888924 DOI: 10.1016/j.athoracsur.2020.06.078] [Reference Citation Analysis]
4 Hamaji M, Shah RM, Ali SO, Bettenhausen A, Lee H, Burt BM. A Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma. The Annals of Thoracic Surgery 2017;103:1668-75. [DOI: 10.1016/j.athoracsur.2016.12.042] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
5 Tateishi Y, Horita N, Namkoong H, Enomoto T, Takeda A, Kaneko T. Postoperative Radiotherapy for Completely Resected Masaoka/Masaoka-Koga Stage II/III Thymoma Improves Overall Survival: An Updated Meta-Analysis of 4746 Patients. J Thorac Oncol 2021;16:677-85. [PMID: 33515812 DOI: 10.1016/j.jtho.2020.12.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Piton N. Histoséminaire de pathologie oncothoracique : cas no 5. Annales de Pathologie 2022. [DOI: 10.1016/j.annpat.2021.12.012] [Reference Citation Analysis]
7 He DC, Zhu ZJ, Zhang XY, Zhang Y, Hong J, Shi TT, Han JH. Dosimetric analysis of postoperative radiotherapy for thymoma. Cancer Radiother 2021:S1278-3218(21)00253-5. [PMID: 34728117 DOI: 10.1016/j.canrad.2021.07.037] [Reference Citation Analysis]
8 Basse C, Botticella A, Molina TJ, Falcoz PE, Oulkhouir Y, Kerjouan M, Pichon E, Westeel V, Thiberville L, Quantin X, Clément-Duchêne C, Khalifa J, Tinier FL, Ginoux M, Thillays F, Mordant P, Besse B, Thomas PA, Péchoux CL, Girard N. RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical Resection. Clin Lung Cancer 2021:S1525-7304(21)00023-1. [PMID: 33736940 DOI: 10.1016/j.cllc.2021.01.020] [Reference Citation Analysis]
9 Kim S, Bull DA, Hsu CH, Hsu CC. The Role of Adjuvant Therapy in Advanced Thymic Carcinoma: A National Cancer Database Analysis. Ann Thorac Surg 2020;109:1095-103. [PMID: 31877285 DOI: 10.1016/j.athoracsur.2019.11.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
10 Vogel J, Lin L, Litzky LA, Berman AT, Simone CB 2nd. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma. Int J Radiat Oncol Biol Phys. 2017;99:427-433. [PMID: 28871993 DOI: 10.1016/j.ijrobp.2017.04.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
11 Lu CF, Yu L, Jing Y, Zhang YF, Ke J. Value of Adjuvant Radiotherapy for Thymoma with Myasthenia Gravis after Extended Thymectomy. Chin Med J (Engl) 2018;131:927-32. [PMID: 29664052 DOI: 10.4103/0366-6999.229894] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Liu H, Gu Z, Qiu B, Detterbeck FC, Roden AC, Ruffini E, Okumura M, Girard N, Xiang Y, Liu Y, Du Z, Hao Y, Fu J, Zhang P, Pang L, Chen K, Wang Y, Yu Z, Mao T, Fang W; AME Thoracic Surgery Cooperative Group. A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database Study. J Thorac Oncol 2020;15:448-56. [PMID: 31726106 DOI: 10.1016/j.jtho.2019.10.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
13 Song SH, Suh JW, Yu WS, Byun GE, Park SY, Lee CY, Kim DJ, Paik HC, Chung KY, Lee GD, Choi S, Kim HR, Kim YH, Kim DK, Park SI, Cho JH, Kim HK, Choi YS, Kim J, Zo JI, Shim YM, Hwang Y, Park S, Park IK, Kang CH, Kim YT, Lee JG. The role of postoperative radiotherapy in stage II and III thymoma: a Korean multicenter database study. J Thorac Dis 2020;12:6680-9. [PMID: 33282369 DOI: 10.21037/jtd-20-1713] [Reference Citation Analysis]
14 Basse C, Thureau S, Bota S, Dansin E, Thomas PA, Pichon E, Lena H, Massabeau C, Clément-Duchene C, Massard G, Westeel V, Quantin X, Oulkhouir Y, Danhier S, Lerouge D, Tanguy R, Thillays F, Le Pechoux C, Dubray B, Thiberville L, Besse B, Girard N. Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort. J Thorac Oncol 2017;12:1715-22. [PMID: 28774861 DOI: 10.1016/j.jtho.2017.07.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
15 Rico M, Flamarique S, Casares C, García T, López M, Martínez M, Serrano J, Blanco M, Hernanz R, de Ingunza-Barón L, Marcos FJ, Couñago F. GOECP/SEOR radiotherapy guidelines for thymic epithelial tumours. World J Clin Oncol 2021; 12(4): 195-216 [PMID: 33959475 DOI: 10.5306/wjco.v12.i4.195] [Reference Citation Analysis]
16 Wen J, Chen J, Chen D, Liu D, Xu X, Huang L, Cao J, Zhang J, Gu Y, Fan M, Chen Y. Evaluation of the prognostic value of surgery and postoperative radiotherapy for patients with thymic neuroendocrine tumors: A propensity-matched study based on the SEER database. Thorac Cancer 2018;9:1603-13. [PMID: 30276969 DOI: 10.1111/1759-7714.12868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Detterbeck FC, Gould MK, Lewis SZ, Patel S. Extending the Reach of Evidence-Based Medicine: A Proposed Categorization of Lower-Level Evidence. Chest 2018;153:498-506. [PMID: 28923759 DOI: 10.1016/j.chest.2017.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 McGunigal M, Margolis M, Forsthoefel M, Singh T, Amarell K, Deblois D, Campbell L, Kim C, Liu S, Bergquist PJ, Debrito P, Collins BT, Giaccone G, Lischalk JW. Thymic malignancies treated with active scanning proton beam radiation and Monte Carlo planning: early clinical experience. Acta Oncol 2021;60:649-52. [PMID: 33629926 DOI: 10.1080/0284186X.2021.1887516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Rappaport JMP, Huang J, Ahmad U. Thymic Malignancy-Updates in Staging and Management. Surg Oncol Clin N Am 2020;29:581-601. [PMID: 32883460 DOI: 10.1016/j.soc.2020.06.010] [Reference Citation Analysis]
20 Drevet G, Collaud S, Tronc F, Girard N, Maury JM. Optimal management of thymic malignancies: current perspectives. Cancer Manag Res 2019;11:6803-14. [PMID: 31413632 DOI: 10.2147/CMAR.S171683] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
21 Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, Koshy M, Kavanagh BD, Gaspar LE, Rusthoven CG. The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol 2017;12:734-44. [PMID: 28126540 DOI: 10.1016/j.jtho.2017.01.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
22 Patel SH, Rimner A, Cohen RB. Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors. Transl Lung Cancer Res 2017;6:186-95. [PMID: 28529901 DOI: 10.21037/tlcr.2017.03.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
23 Girard N. Neuroendocrine tumors of the thymus: the oncologist point of view. J Thorac Dis 2017;9:S1491-500. [PMID: 29201452 DOI: 10.21037/jtd.2017.08.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
24 Tanaka Y, Hokka D, Ogawa H, Shimizu N, Inoue T, Tanaka H, Okita Y, Maniwa Y. Surgery for malignant lesions of the chest which extensively involved the mediastinum, lung, and heart. Gen Thorac Cardiovasc Surg 2017;65:365-73. [PMID: 28540630 DOI: 10.1007/s11748-017-0782-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Ruffini E, Filosso PL, Guerrera F, Lausi P, Lyberis P, Oliaro A. Optimal surgical approach to thymic malignancies: New trends challenging old dogmas. Lung Cancer 2018;118:161-70. [DOI: 10.1016/j.lungcan.2018.01.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
26 Basse C, Merveilleux du Vignaux C, Girard N. Postoperative Radiotherapy in Completely Resected Stage II and III Thymoma: How to Translate the Potential Survival Benefit in the Setting of the Future Adoption of the IASLC-ITMIG TNM-Based Staging System. Journal of Thoracic Oncology 2017;12:e8-9. [DOI: 10.1016/j.jtho.2016.09.128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
27 Bruni A, Stefani A, Perna M, Borghetti P, Giaj Levra N, D'Angelo E, D'Onofrio A, Rubino L, Frassinelli L, Salvestrini V, Mariotti M, Alongi F, Gonfiotti A, Livi L, Scotti V. The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature. J Thorac Dis 2020;12:7518-30. [PMID: 33447442 DOI: 10.21037/jtd-2019-thym-09] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Ried M, Eicher MM, Neu R, Sziklavari Z, Hofmann HS. Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival. World J Surg Oncol. 2017;15:214. [PMID: 29197400 DOI: 10.1186/s12957-017-1283-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
29 Ruffini E, Fang W, Guerrera F, Huang J, Okumura M, Kim DK, Girard N, Billè A, Boubia S, Cangir AK, Detterbeck F, Falkson C, Filosso PL, Giaccone G, Kondo K, Infante M, Lucchi M, Marino M, Marom EM, Nicholson AG, Rimner A, Rami-porta R, Asamura H. The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors. Journal of Thoracic Oncology 2020;15:436-47. [DOI: 10.1016/j.jtho.2019.11.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
30 Soldera SV, Shakik S, Naik H, Moskovitz M, Chen J, Mittmann N, Xu W, Hope A, Bezjak A, Parajian A, Keshavjee S, Liu G. Favourable health-related quality of life reported in survivors of thymic malignancies. Eur J Cardiothorac Surg 2019;55:292-9. [PMID: 30084958 DOI: 10.1093/ejcts/ezy259] [Reference Citation Analysis]
31 Imbimbo M, Ottaviano M, Vitali M, Fabbri A, Leuzzi G, Fiore M, Franceschini D, Pasello G, Perrino M, Schiavon M, Pruneri G, Dei Tos AP, Sangalli C, Garassino MC, Berardi R, Alessi A, Calareso G, Petrini I, Scorsetti M, Scotti V, Rosso L, Rea F, Pastorino U, Casali PG, Ramella S, Ricardi U, Abate-Daga L, Torri V, Trama A, Palmieri G, Marino M, Zucali PA;  TYME network collaborators. Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). Cancer Treat Rev. 2018;71:76-87. [PMID: 30366202 DOI: 10.1016/j.ctrv.2018.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
32 Süveg K, Putora PM, Joerger M, Iseli T, Fischer GF, Ammann K, Glatzer M. Radiotherapy for thymic epithelial tumours: a review. Transl Lung Cancer Res 2021;10:2088-100. [PMID: 34012817 DOI: 10.21037/tlcr-20-458] [Reference Citation Analysis]
33 Yang AJ, Choi SH, Byun HK, Kim HJ, Lee CG, Cho J. The role of salvage radiotherapy in recurrent thymoma. Radiat Oncol J 2019;37:193-200. [PMID: 31591867 DOI: 10.3857/roj.2019.00066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Basse C, Girard N. Thymic tumours and their special features. Eur Respir Rev 2021;30:200394. [PMID: 34670805 DOI: 10.1183/16000617.0394-2020] [Reference Citation Analysis]
35 Willmann J, Rimner A. The expanding role of radiation therapy for thymic malignancies. J Thorac Dis. 2018;10:S2555-S2564. [PMID: 30206499 DOI: 10.21037/jtd.2018.01.154] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
36 Mou H, Liao Q, Hou X, Chen T, Zhu Y. Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988-2013). Int J Radiat Biol 2018;94:495-502. [PMID: 29553917 DOI: 10.1080/09553002.2018.1454618] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
37 Mercado CE, Hartsell WF, Simone CB, Tsai HK, Vargas CE, Zhu HJ, Henderson RH, Zeng J, Larson GL, Hoppe BS. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries. Acta Oncologica 2019;58:1036-40. [DOI: 10.1080/0284186x.2019.1575981] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
38 Khorfan R, Bharat A, Odell DD. Management and Long-Term Outcomes of Advanced Stage Thymoma in the United States. Ann Thorac Surg 2021;111:223-30. [PMID: 32659263 DOI: 10.1016/j.athoracsur.2020.05.088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
39 Lee KH, Noh JM, Ahn YC, Oh D, Kim J, Shim YM, Han JH. Patterns of Failure Following Postoperative Radiation Therapy Based on "Tumor Bed With Margin" for Stage II to IV Type C Thymic Epithelial Tumor. Int J Radiat Oncol Biol Phys 2018;102:1505-13. [PMID: 30099130 DOI: 10.1016/j.ijrobp.2018.07.2022] [Reference Citation Analysis]
40 Turna A, Sarbay İ. Multimodality approach in treatment of thymic tumors. J Thorac Dis 2020;12:7626-34. [PMID: 33447454 DOI: 10.21037/jtd-20-818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]